01 BMR Placebo Tablets

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 10

BATCH MANUFACTURING, FORMULA, METHOD AND RECORD

ASCORBIC ACID EFFERVESCENT TABLETS Batch: Scale-Up


(EFF-CEE)
Form: EFFERVESCENT TABLET Batch Size: 600 TABLETS
PROCESS START AND COMPLETION TIMES
START: TIME: COMPLETION: TIME:
DATE: DATE:

ASSIGNMENT OF ROLES
NAME ROLE INITIALS SIGNATURE
BALUTOC, Iris Patrisha Supervisor
GONZAGA, Mary France Production Head
SORIA, Marie Claire Production
DELA ROSA, Paula Dispensing
PO, Sharmaine Kae Quality Assurance/ Quality Control
VILLAFUERTE, Jillian Quality Assurance/ Quality Control
LEGASPI, Donato Packaging and Labelling
ARGONZA, Femina Maintenance

FORMULA AND WEIGHING RECORD


ACTUAL
CODE MATERIAL AMOUNT DISPENSED BY CHECKED BY
AMOUNT
Ascorbic Acid 300 g
F19 PVP 72 g
N/A 95% Ethanol 175 mL
J5 Sucrose 36 g
Aspartame 16.20 g
E12 Citric Acid Monohydrate 180 g
J8 Tartaric Acid 90 g
Sodium Bicarbonate 360 g
PEG 6000 28.80 g
C25 Orange flavour (powder) 117 g

Name of Dispenser: _____________________________ Name of Checker: ______________________________


Signature: _______________________________________ Signature: ______________________________________

Batch Document Issued by: BALUTOC, Iris Patrisha Abigail C. Date: ______________________

MASTER DOCUMENT EFFECTIVE: 28 Aug 2015 SUPERSEDES: N/A


Prepared by: Approved by: Production:

BALUTOC, Iris Patrisha Abigail C. PO, Sharmaine Kae D. GONAZAGA, Mary France R.
Date: Date: Date:

Page 1 of 10

BATCH MANUFACTURING, FORMULA, METHOD AND RECORD

ASCORBIC ACID EFFERVESCENT TABLETS Batch: Scale-Up


(EFF-CEE)
Form: EFFERVESCENT TABLET Batch Size: 600 TABLETS
PROCESS START AND COMPLETION TIMES
START: TIME: COMPLETION: TIME:
DATE: DATE:

MANUFACTURING LOCATION: Solids Room, Industrial Pharmacy Laboratory, College of Pharmacy,
University of the Philippines, Manila

MAJOR EQUIPMENT: Sigma Blade Mixer – Model: Stokes F


Tablet Press – Model: Stokes F
Oscillating Granulator – Model: Stokes F, Single Arm Mixer
Drying Oven – Model:

MANUFACTURING INSTRUCTIONS AND RECORD

Name of Operator: _____________________________ Name of Checker: ______________________________


Signature: ______________________________________ Signature: ______________________________________

PROCEDURE DATE TIME PERFORMED BY CHECKED BY


1. Check the Plant Log, and enter Start:
details of following: End:
1.1 Previous equipment use:
Product:
Batch No.
Date
1.2 Last equipment cleandown
Date
Start:
2. Obtain clearance from Production
End:
Supervisor and QC that equipment
is clean and ready for use
Maintenance
QC clearance
Production
Supervisor clearance


Batch Document Issued by: BALUTOC, Iris Patrisha Abigail C. Date: ______________________

MASTER DOCUMENT EFFECTIVE: 28 Aug 2015 SUPERSEDES: N/A


Prepared by: Approved by: Production:

BALUTOC, Iris Patrisha Abigail C. PO, Sharmaine Kae D. GONAZAGA, Mary France R.
Date: Date: Date:

Page 2 of 10

BATCH MANUFACTURING, FORMULA, METHOD AND RECORD

ASCORBIC ACID EFFERVESCENT TABLETS Batch: Scale-Up


(EFF-CEE)
Form: EFFERVESCENT TABLET Batch Size: 600 TABLETS
PROCESS START AND COMPLETION TIMES
START: TIME: COMPLETION: TIME:
DATE: DATE:

3. Prepare granulating solution by Start:
adding PVP to ethanol. End:
4. Screen citric acid and tartaric acid Start:
End:
through a no. 40 Sieve. This is
granulation A.
5. Screen sodium bicarbonate through Start:
a no. 40 Sieve. This is granulation B. End:
6. Screen ascorbic acid, PEG 6000,
sucrose, aspartame, powdered Start:
orange flavour separately through a End:
no. 40 sieve.
7. Transfer granulation A to the sigma Start:
blade mixer and add enough End:
granulating solution; mix until the
endpoint is reached.
Start:
st
1 addition End:

Start:
nd
2 addition End:

Start:
rd
3 addition End:

Start:
th
4 addition End:

Start:
th
5 addition End:

Batch Document Issued by: BALUTOC, Iris Patrisha Abigail C. Date: ______________________

MASTER DOCUMENT EFFECTIVE: 28 Aug 2015 SUPERSEDES: N/A


Prepared by: Approved by: Production:

BALUTOC, Iris Patrisha Abigail C. PO, Sharmaine Kae D. GONAZAGA, Mary France R.
Date: Date: Date:

Page 3 of 10

BATCH MANUFACTURING, FORMULA, METHOD AND RECORD

ASCORBIC ACID EFFERVESCENT TABLETS Batch: Scale-Up


(EFF-CEE)
Form: EFFERVESCENT TABLET Batch Size: 600 TABLETS
PROCESS START AND COMPLETION TIMES
START: TIME: COMPLETION: TIME:
DATE: DATE:


Start:
8. Pass the moistened mass formed
End:
into balls through a no. 4 mesh
screen. (Granules A)

9. Spread the moist Granules A on trays Start:


and place in the drying oven set at End:
60°C for 15-30 minutes.
Start:
10. Determine LOD of dried granules A. End:

Start:
11. Re-dry granules A if moisture End:
content is more than 5%.

Start:
12. Pass the dried granules A through End:
the oscillating granulator with a no.
20 screen attached.

Start:
13. Regranulate the portion of granules End:
A that passes through sieve no. 40.

14. Combine the good granules and Start:


fines of A (10% of the weight of the End:
good granules).
Weight of Good A _______________
Weight of Fine A _______________

Batch Document Issued by: BALUTOC, Iris Patrisha Abigail C. Date: ______________________

MASTER DOCUMENT EFFECTIVE: 28 Aug 2015 SUPERSEDES: N/A


Prepared by: Approved by: Production:

BALUTOC, Iris Patrisha Abigail C. PO, Sharmaine Kae D. GONAZAGA, Mary France R.
Date: Date: Date:

Page 4 of 10

BATCH MANUFACTURING, FORMULA, METHOD AND RECORD

ASCORBIC ACID EFFERVESCENT TABLETS Batch: Scale-Up


(EFF-CEE)
Form: EFFERVESCENT TABLET Batch Size: 600 TABLETS
PROCESS START AND COMPLETION TIMES
START: TIME: COMPLETION: TIME:
DATE: DATE:

15. Transfer granulation B to the sigma Start:
blade mixer and add enough End:
granulating solution; mix until the
endpoint is reached.
Start:
st
1 addition End:

Start:
nd
2 addition End:

Start:
rd
3 addition End:

Start:
th
4 addition End:

Start:
th
5 addition End:

16. Pass the moistened mass formed Start:


into balls through a no. 4 mesh End:
screen. (Granules B)
17. Spread the moist Granules B on Start:
trays and place in the drying oven End:
set at 60°C for 15-30 minutes.
Start:
18. Determine LOD of dried granules B. End:

Start:
19. Re-dry granules B if moisture
End:
content is more than 5%.


Batch Document Issued by: BALUTOC, Iris Patrisha Abigail C. Date: ______________________

MASTER DOCUMENT EFFECTIVE: 28 Aug 2015 SUPERSEDES: N/A


Prepared by: Approved by: Production:

BALUTOC, Iris Patrisha Abigail C. PO, Sharmaine Kae D. GONAZAGA, Mary France R.
Date: Date: Date:

Page 5 of 10

BATCH MANUFACTURING, FORMULA, METHOD AND RECORD

ASCORBIC ACID EFFERVESCENT TABLETS Batch: Scale-Up


(EFF-CEE)
Form: EFFERVESCENT TABLET Batch Size: 600 TABLETS
PROCESS START AND COMPLETION TIMES
START: TIME: COMPLETION: TIME:
DATE: DATE:

20. Pass the dried granules B through Start:
the oscillating granulator with a no. End:
20 screen attached.
Start:
21. Regranulate the portion of granules End:
B that passes through sieve no. 40.

22. Combine the good granules and Start:


fines of B (10% of the weight of the End:
good granules).
Weight of Good B _______________
Weight of Fine B _______________
23. Transfer granules A, granules B, Start:
sucrose, aspartame, and the End:
orange powder flavor to a clear,
polyethylene bag.
Start:
24. Transfer the screened ascorbic acid
End:
into the polyethylene bag.
Start:
25. Tumble-mix the powders for 10
End:
minutes.

Start:
26. Add the screened PEG 6000 into the
End:
polyethylene bag.

Start:
27. Tumble-mix the powders for 3
End:
minutes.
28. After mixing, obtain the weight of Start:
the combined powders and End:
granules. Label the bag as, “For
tableting”.
Batch Document Issued by: BALUTOC, Iris Patrisha Abigail C. Date: ______________________

MASTER DOCUMENT EFFECTIVE: 28 Aug 2015 SUPERSEDES: N/A


Prepared by: Approved by: Production:

BALUTOC, Iris Patrisha Abigail C. PO, Sharmaine Kae D. GONAZAGA, Mary France R.
Date: Date: Date:

Page 6 of 10

BATCH MANUFACTURING, FORMULA, METHOD AND RECORD

ASCORBIC ACID EFFERVESCENT TABLETS Batch: Scale-Up


(EFF-CEE)
Form: EFFERVESCENT TABLET Batch Size: 600 TABLETS
PROCESS START AND COMPLETION TIMES
START: TIME: COMPLETION: TIME:
DATE: DATE:


29. Perform In-Process Quality Control Start:
on the combined granules. End:

Start:
a. Bulk Density
End:

Start:
Tapped Density
End:

Start:
b. Angle of Repose End:

Start:
c. Compressibility Index End:

Start:
Hausner Ratio End:

Start:
d. Moisture Content End:

Start:
e. Particle Size Distribution End:

Start:
30. Compress into tablets using ¾’ End:
punches.

Batch Document Issued by: BALUTOC, Iris Patrisha Abigail C. Date: ______________________

MASTER DOCUMENT EFFECTIVE: 28 Aug 2015 SUPERSEDES: N/A


Prepared by: Approved by: Production:

BALUTOC, Iris Patrisha Abigail C. PO, Sharmaine Kae D. GONAZAGA, Mary France R.
Date: Date: Date:

Page 7 of 10

BATCH MANUFACTURING, FORMULA, METHOD AND RECORD

ASCORBIC ACID EFFERVESCENT TABLETS Batch: Scale-Up


(EFF-CEE)
Form: EFFERVESCENT TABLET Batch Size: 600 TABLETS
PROCESS START AND COMPLETION TIMES
START: TIME: COMPLETION: TIME:
DATE: DATE:

Start:
31. Compress into tablets using 7/16’ End:
flat, concave punches.

32. Perform FPQC every ten minutes Start:


and record as X on the control End:
chart. Record all retest as R.

Start:
a. Physical appearance and taste
End:
b. pH Start:
End:
c. Hardness Start:
End:
d. Thickness Start:
End:
e. Weight Variation Start:
End:
f. Friability Start:
End:
g. Effervescence Start:
End:
h. Assay Start:
End:
Start:
33. Calculate theoretical and actual
End:
yield. Account for losses.
Theoretical Yield _________________
Actual Yield ______________________
Losses ___________________________

Batch Document Issued by: BALUTOC, Iris Patrisha Abigail C. Date: ______________________

MASTER DOCUMENT EFFECTIVE: 28 Aug 2015 SUPERSEDES: N/A


Prepared by: Approved by: Production:

BALUTOC, Iris Patrisha Abigail C. PO, Sharmaine Kae D. GONAZAGA, Mary France R.
Date: Date: Date:

Page 8 of 10

BATCH MANUFACTURING, FORMULA, METHOD AND RECORD

ASCORBIC ACID EFFERVESCENT TABLETS Batch: Scale-Up


(EFF-CEE)
Form: EFFERVESCENT TABLET Batch Size: 600 TABLETS
PROCESS START AND COMPLETION TIMES
START: TIME: COMPLETION: TIME:
DATE: DATE:

STANDARD ACCEPTABLE BULK YIELD: 570 – 630 TABLETS

Arrange for sample of bulk product to be taken by QC sampler

AUTHORIZED DEVIATIONS FROM THE STANDARD PROCEDURE:

PRIOR AUTHORIZATION:
Production: _______________ QA: ________________________
Date: ______________________ Date: ______________________

NON-STANDARD EVENT RECORD (Include any explanation of any non-standard yield)

Batch Document Issued by: BALUTOC, Iris Patrisha Abigail C. Date: ______________________

MASTER DOCUMENT EFFECTIVE: 28 Aug 2015 SUPERSEDES: N/A


Prepared by: Approved by: Production:

BALUTOC, Iris Patrisha Abigail C. PO, Sharmaine Kae D. GONAZAGA, Mary France R.
Date: Date: Date:

Page 9 of 10

BATCH MANUFACTURING, FORMULA, METHOD AND RECORD

ASCORBIC ACID EFFERVESCENT TABLETS Batch: Scale-Up


(EFF-CEE)
Form: EFFERVESCENT TABLET Batch Size: 600 TABLETS
PROCESS START AND COMPLETION TIMES
START: TIME: COMPLETION: TIME:
DATE: DATE:

PRODUCTION CERTIFICATION: Apart from any authorized deviations, or non-standard events, as


recorded above, this batch has been manufactured in accordance with this BATCH MANUFACTURING
FORMULA, METHOD, and RECORD.

Production Supervisor: ______________________


Signature: ___________________________________
Date: ________________________________________

QUALITY CONTROL APPROVAL FOR PACKAGING

This bulk batch of PLACEBO TABLETS Batch Scale-Up


Has been sampled and tested, and is RELEASED FOR PACKAGING.

Quality Control: _____________________________


Signature: ___________________________________
Date: ________________________________________

-NOTHING FOLLOWS-

Batch Document Issued by: BALUTOC, Iris Patrisha Abigail C. Date: ______________________

MASTER DOCUMENT EFFECTIVE: 28 Aug 2015 SUPERSEDES: N/A


Prepared by: Approved by: Production:

BALUTOC, Iris Patrisha Abigail C. PO, Sharmaine Kae D. GONAZAGA, Mary France R.
Date: Date: Date:

Page 10 of 10

You might also like